Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications section description was updated to indicate PubMed as the data source and that publications may not all pertain to the study; the revision note shows an update from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe top-level notice about government funding and NIH operating status has been removed. The page still presents the study details, eligibility criteria, and locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedNon-significant changes observed: the page retains the same study details with only minor formatting/UI adjustments and no new or removed critical information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedAdd: new operating-status notice and v3.2.0 release; Remove: previously listed resource topic (B-cell chronic lymphocytic leukemia) and v3.1.0 reference. The page now highlights current operating status and updated version, while some resource entries were trimmed.SummaryDifference3%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.